ABBV vs LCNB · P/E 81, rev $16.99B vs P/E 10, rev $51.8M
AbbVie Inc (ABBV) versus LCNB Corporation (LCNB) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
LCNB Corporation (LCNB) is a banks - regional company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported LCNB revenue for 2026-06-30 was $51.8M. Net income was $11.9M. LCNB currently screens at market cap $238.6M and trailing P/E 10.4.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. LCNB currently screens at market cap $238.6M and trailing P/E 10.4.
Not investment advice. Open the ABBV and LCNB stock pages for the full models.
Not investment advice.